Karin Rosen is a medical and biotechnology/pharmaceutical Senior Executive and Chief Scientific Officer with comprehensive biotech/pharmaceutical industry experience. Karin has directed international clinical research and development programs in Product Development and holds a substantiated track record of building, leading, and successfully launching multiple novel drugs within the US and Global Medical Affairs in the fields of oncology, immunology, respiratory, dermatology and infectious disease. Karin is praised as both dynamic and driven and is recognized for her ability to attract top talent and build and lead international multifunctional teams in the US and globally.
Karin has experience in effectively managing US and global teams of SVPs; VPs TA Heads; Medical Experts; including Health Economic Outcomes, RWD, as well as the medical field force. Karin’s previous professional experience at Horizon Therapeutics included being a member of the Executive Leadership Team and being responsible for leading and managing the early- and late- stage R&D organization. She carried out responsibilities related to setting the R&D strategy of developing innovative therapeutics to address patient’s unfulfilled medical needs in the areas of immunology, autoimmune, and severe inflammatory diseases. Karin is a seasoned executive whose expertise is critical to company functioning.